Showing results (191-200 of 830) with videos related to
Sort By:
Pageof 83
Pharmacogenetics|April 3, 2002
Cytochrome P450 2C9 polymorphisms: a comprehensive review of the in-vitro and human dataCraig R Lee, Joyce A Goldstein, John A PieperPharmacogenetics|March 25, 1998
Genetic linkage mapping of the CYP11A1 gene encoding the cholesterol side-chain cleavage P450scc close to the CYP1A1 gene and D15S204 in the chromosome 15q22.33-q23 regionF Durocher, J Morissette, J SimardPharmacogenetics|January 16, 1998
Developmental expression of CYP2C and CYP2C-dependent activities in the human liver: in-vivo/in-vitro correlation and inducibilityJ M Treluyer, G Gueret, G Cheron, et al.Pharmacogenetics|January 16, 1998
A population-based case-control study of the CYP2D6 and GSTT1 polymorphisms and malignant brain tumorsK T Kelsey, M Wrensch, Z F Zuo, et al.Pharmacogenetics|January 16, 1998
A monoclonal antibody inhibitory to human P450 2D6: a paradigm for use in combinatorial determination of individual P450 role in specific drug tissue metabolismH V Gelboin, K W Krausz, M Shou, et al.Pharmacogenetics|June 1, 1995
Genetic analysis of the CYP2D locus in relation to debrisoquine hydroxylation capacity in Korean, Japanese and Chinese subjectsM L Dahl, Q Y Yue, H K Roh, et al.Pharmacogenetics|January 1, 1995
Polymorphic forms of the Ah receptor and induction of the CYP1A1 geneY Fujii-Kuriyama, M Ema, J Mimura, et al.Pharmacogenetics|August 1, 1995
Human variability in hepatic glutathione S-transferase-mediated conjugation of aflatoxin B1-epoxide and other substratesD H Slone, E P Gallagher, H S Ramsdell, et al.Pharmacogenetics|November 3, 2001
Influence of the dopamine D2 receptor (DRD2) exon 8 genotype on efficacy of tiapride and clinical outcome of alcohol withdrawalM J Lucht, K U Kuehn, W Schroeder, et al.Pharmacogenetics|April 15, 2004
Vitamin D receptor gene polymorphism as an important modifier of positive family history related breast cancer riskPia Sillanpää, Ari Hirvonen, Vesa Kataja, et al.Pageof 83